SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

Rubius Therapeutics Posts Narrower Q1 Loss

05/10/2021 05:46

09:43 AM EDT, 05/10/2021 (MT Newswires) -- Rubius Therapeutics (RUBY) on Monday reported a Q1 net loss of $0.51 per share, compared with $0.60 loss per share last year. Analysts polled by Capital IQ had called for $0.53 loss per share. The company reported no revenue, as expected.

The clinical-stage company said it ended Q1 with $330.7 million of cash, cash equivalents and investments, up from $176.3 million at the end of Q4.

Price: 24.88, Change: -1.27, Percent Change: -4.86